HTG Provides Update On Third Quarter Progress Toward Its Transcriptome-Informed Approach to Drug Discovery, Says Completed Planned Milestones For Q3’22
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, completed its planned milestones for the third